Citigroup starts Arrowhead Pharmaceuticals with a $108 price target
Citigroup initiated coverage on Arrowhead Pharmaceuticals with a buy rating and announced a $108.00/share price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.